Credit Suisse’s Arrangement of Financing for WellPoint’s Acquisition of Amerigroup
July 10, 2012
On July 9, 2012, WellPoint, Inc. and Amerigroup Corporation announced that they have entered into a definitive agreement through which WellPoint will acquire Amerigroup, one of the nation’s leading managed care companies, for approximately $4.9 billion. Cravath represented Credit Suisse, lead arranger of $3 billion in committed financing to WellPoint in connection with this transaction. The acquisition is expected to close in the first quarter of 2013.
The Cravath team included partners Michael S. Goldman and William J. Whelan III and associates Katerina M. Novak and Benjamin S. Persina.
Related Practices & Industries
People
- Photo
-
-
J.D., 1987, Fordham University School of Lawcum laude
-
B.A., 1984, University of Pennsylvaniacum laude
Education
- Photo
-
-
J.D., 1983, Fordham University School of Lawcum laude
-
B.A., 1980, University of Virginiawith Distinction
Education
Related News & Insights
Deals & Cases
February 20, 2026
First Solar’s $1.5 Billion Revolving Credit Facility
Cravath represented First Solar, Inc. in connection with its $1.5 billion revolving credit facility. First Solar is America’s leading photovoltaic solar technology and manufacturing company, and the only US‑headquartered company among the world’s largest solar manufacturers. The transaction closed on February 13, 2026.
Deals & Cases
January 08, 2026
Genmab’s $3.5 Billion of Credit Facilities and Offering of $1.5 Billion Senior Secured Notes and $1 Billion Senior Unsecured Notes in Connection with its Acquisition of Merus
Cravath represented the administrative agent, joint lead arrangers and joint bookrunners in connection with $3.5 billion of credit facilities made available to Genmab, a leading international biotechnology company, and one of its wholly‑owned subsidiaries, Genmab Finance LLC, as part of the financing transactions undertaken in connection with its acquisition of Merus N.V., a leading oncology company developing innovative antibody therapeutics. The credit facilities consisted of a $2 billion term loan “B” facility, a $1 billion term loan “A” facility and a $500 million revolving credit facility. The transaction closed on December 12, 2025.
Deals & Cases
December 24, 2025
Ameren’s $3.2 Billion of Revolving Credit Facilities
Cravath represented the administrative agent, joint lead arranger and joint bookrunner in connection with $3.2 billion of revolving credit facilities made available to Ameren Corporation and Union Electric Company (the “Missouri Borrowers”) and Ameren Corporation and Ameren Illinois Company (the “Illinois Borrowers”). Ameren Corporation is an American power company that engages in the rate‑regulated electric generation, transmission and distribution activities; and rate‑regulated natural gas distribution and transmission businesses. The facilities consisted of a $1.9 billion revolving credit facility (Missouri Borrowers) and $1.3 billion revolving credit facility (Illinois Borrowers). The transaction closed on December 10, 2025.
Deals & Cases
November 24, 2025
Thomson Reuters Corporation’s $2 Billion Revolving Credit Facility
Cravath represented the administrative agent, joint lead arranger and joint bookrunner in connection with a $2 billion revolving credit facility made available to Thomson Reuters Corporation, a leading AI and technology company empowering professionals with trusted content and workflow automation. The transaction closed on November 10, 2025.
